Rosenblatt raises Coherent stock price target on transceiver growth By Investing.com

Rosenblatt raised Coherent’s price target to $425 from $375 while keeping a Buy rating, implying meaningful upside from the current $344.67 share price. The firm expects fourth-quarter 2026 growth to be driven by transceivers and optical circuit switching, with gross margins potentially reaching the high end of 39% to 41% guidance. Coherent also recently reported record fiscal Q3 2026 revenue of $1.8 billion and EPS of $1.41, above the $1.39 forecast.

Analysis

The cleaner read-through is not just improving AI optics demand; it is a relative winner-loser setup within the photonics supply chain. A faster ramp in one vendor’s internal component capability should pressure the market to re-rate vertically integrated players versus those dependent on third-party sourcing, because execution visibility matters more than headline TAM at this stage. That also means the next leg of outperformance likely comes from margin expansion and mix shift, not just top-line beats.

The key second-order effect is that the market may be underestimating how early customer qualification can become a moat. If one supplier is pulling forward availability on critical components, hyperscaler procurement teams will preferentially dual-source toward the one with the shortest delivery risk and highest yield stability, which can create a winner-take-more dynamic in 2026–2027. That creates a real knock-on risk for the main public peer: any delay in its own supply-chain normalization could compress valuation multiples even if end demand remains intact.

Short term, the stock can keep grinding higher on estimate revisions, but the risk/reward is becoming more timing-sensitive after such a large move. The main downside catalyst is not demand failure; it is any sign that the 2026 ramp slips into calendar 2027, because the current multiple is already discounting a clean execution path. A second risk is that gross margin optimism proves too aggressive if mix or ramp costs offset operating leverage.

Contrarianly, the consensus may be overpaying for the next 12 months while underpricing the 24-month compounding. The trade is likely best expressed as a relative-value expression rather than outright momentum chasing, because the setup depends on path confirmation more than final demand size.

Key Decisions for Investors

• Stay long COHR, but use pullbacks toward the prior breakout zone to add rather than chase; 3-6 month horizon with upside tied to repeated margin/guide revisions, not just multiple expansion.
• Pair trade: long COHR / short LITE for the next 6-9 months. Thesis: execution and supply-chain control should sustain a valuation premium, while peer dependence on suppliers keeps timing risk elevated.
• If already long COHR, buy downside protection via 3-4 month puts financed with calls above the recent high; this keeps upside exposure while limiting damage if the 2026 ramp narrative slips.
• For tactical traders, consider a post-earnings momentum add only if management confirms margin at the top end of guidance; otherwise expect a mean-reversion window over the next 2-4 weeks.
• Avoid initiating a fresh outright short in LITE unless there is evidence of customer share loss; the better expression is relative underweight versus COHR, since the market may already be partially discounting the delay risk.